Видео ютуба по тегу Generic Drug Access India

Natco vs Roche: India’s Big Win for Affordable SMA Treatment!
Natco vs Roche: India’s Big Win for Affordable SMA Treatment!
AmericanTariffs on Branded Indian Drugs – Will India’s Pharma Suffer#USIndiaRelations #PolicyChange
AmericanTariffs on Branded Indian Drugs – Will India’s Pharma Suffer#USIndiaRelations #PolicyChange
लपेट ली 😮 अमेरिका की दवाइयां | India stops medicine export to USA | India US tarrif | Pm modi
लपेट ली 😮 अमेरिका की दवाइयां | India stops medicine export to USA | India US tarrif | Pm modi
“How India’s Pharma Industry Is Revolutionizing Africa’s Access to Affordable Medicines in 2025
“How India’s Pharma Industry Is Revolutionizing Africa’s Access to Affordable Medicines in 2025
US medicine sent to Russia? | India have $41 Billion Market Access of Russia | Pharma Export Hit |
US medicine sent to Russia? | India have $41 Billion Market Access of Russia | Pharma Export Hit |
Indian Generic Medicines|THE HINDU Newspaper|CurrentwithStatic|UPSC2026|UPPSC2025|Shilpi Verma|#upsc
Indian Generic Medicines|THE HINDU Newspaper|CurrentwithStatic|UPSC2026|UPPSC2025|Shilpi Verma|#upsc
Patents, Prices & Power: How FTAs Threaten Affordable Medicines in India
Patents, Prices & Power: How FTAs Threaten Affordable Medicines in India
Indian Pharma -The Great Access Story| GEMBA Webinar Series
Indian Pharma -The Great Access Story| GEMBA Webinar Series
50% Tax Threatens America's Lifeline: India’s Life-Saving Medicines at Risk | By Anthony Hopkins
50% Tax Threatens America's Lifeline: India’s Life-Saving Medicines at Risk | By Anthony Hopkins
Press Briefing: India‑UK FTA: Implications for Access to Medicines
Press Briefing: India‑UK FTA: Implications for Access to Medicines
The U.S.–India FTA and Beyond: Trade Policy Challenges to Affordable Medicines
The U.S.–India FTA and Beyond: Trade Policy Challenges to Affordable Medicines
US medicine sent to Russia? India has 41 billion dollar market access of Russia | Pharma Export Hit
US medicine sent to Russia? India has 41 billion dollar market access of Russia | Pharma Export Hit
Generic Medicine vs Branded Medicines | জেনেরিক বনাম ব্র্যান্ডেড ওষুধ: পার্থক্য কী?
Generic Medicine vs Branded Medicines | জেনেরিক বনাম ব্র্যান্ডেড ওষুধ: পার্থক্য কী?
Dava India Se Generic Medicine Kaise Order Kare | How To Order Generic Medicine Online | Dava India
Dava India Se Generic Medicine Kaise Order Kare | How To Order Generic Medicine Online | Dava India
India’s Medicine Crisis: Unpacking the Price Tag
India’s Medicine Crisis: Unpacking the Price Tag
The Untold Story of India's Generic Medicine
The Untold Story of India's Generic Medicine
Risdiplam Pharma Ethics, Patents, and Access in India
Risdiplam Pharma Ethics, Patents, and Access in India
How India Is Solving the Healthcare Crisis with generic medicines
How India Is Solving the Healthcare Crisis with generic medicines
Leading Case 29: 3. Novartis AG v. Union of India & Others [2013]
Leading Case 29: 3. Novartis AG v. Union of India & Others [2013]
Leading Case 29: 2. Novartis AG v. Union of India & Others [2013]
Leading Case 29: 2. Novartis AG v. Union of India & Others [2013]
Patent Monopolies Limit Access to Affordable Rare Disease Drugs #healthcare #medicine #diseasefree
Patent Monopolies Limit Access to Affordable Rare Disease Drugs #healthcare #medicine #diseasefree
Beyond the Generic: India's Emerging Role in Pharmaceutical Innovation #india #globalhealthcare
Beyond the Generic: India's Emerging Role in Pharmaceutical Innovation #india #globalhealthcare
#Assignment of Jan Aushadhi and Other Generic Medicine Initiatives in India #Community #DPharm
#Assignment of Jan Aushadhi and Other Generic Medicine Initiatives in India #Community #DPharm
Improving Drug Regulation for Greater Access to Biologics and Vaccines
Improving Drug Regulation for Greater Access to Biologics and Vaccines
Jan Aushadi Kendra, A guarantee of access to affordable & quality medicines for all
Jan Aushadi Kendra, A guarantee of access to affordable & quality medicines for all